Precision Medicine in Asthma-Using Phenotypes to Understand Endotypes That Lead Us to New Therapeutic Options
- 1 February 2020
- journal article
- editorial
- Published by Elsevier BV in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 8 (2), 496-497
- https://doi.org/10.1016/j.jaip.2019.12.001
Abstract
No abstract availableFunding Information
- National Institutes of Health
- American Lung Association
- Patient-Centered Outcomes Research Institute
- PCORI
- AstraZeneca
- GlaxoSmithKline
- GSK
- Sanofi-Aventis
This publication has 10 references indexed in Scilit:
- Diagnosis and Management of T2-High AsthmaThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- T2-“Low” Asthma: Overview and Management StrategiesThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- Eosinophilic AsthmaThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- Allergic Endotypes and Phenotypes of AsthmaThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- Exacerbation-Prone AsthmaThe Journal of Allergy and Clinical Immunology: In Practice, 2019
- Asthma-COPD Overlap and Chronic Airflow Obstruction: Definitions, Management, and Unanswered QuestionsThe Journal of Allergy and Clinical Immunology: In Practice, 2019
- Phenotypes and endotypes of adult asthma: Moving toward precision medicineJournal of Allergy and Clinical Immunology, 2019
- After asthma: redefining airways diseasesLancet, 2018
- The Many “Buckets” of Severe Asthma: Moving Toward Personalized ManagementThe Journal of Allergy and Clinical Immunology: In Practice, 2017
- Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research ProgramAmerican Journal of Respiratory and Critical Care Medicine, 2010